Go Pro
→ Rickards Predicts: Trump to buy tiny $2 stock? (From Paradigm Press) (Ad)tc pixel
NASDAQ:CLIK

Click Q2 2026 Earnings Report

Click logo
$1.43 +0.05 (+3.62%)
As of 09/1/2026 04:00 PM Eastern
ProfileEarnings HistoryForecast

Click EPS Results

Actual EPS
$0.10
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Click Revenue Results

Actual Revenue
$3.79 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Click Announcement Details

Quarter
Q2 2026
Date
5/11/2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Click Earnings Headlines

Click (NASDAQ:CLIK) Trading Up 3.6% - What's Next?
 |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30997775
Click Holdings’ Care U Moves Into Shandong’s Massive Elderly-Care Market
September 1 at 9:50 AM  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/click-holdings-care-u-moves-into-shandongs-massive-elderly-care-market?utm_source=marketbeat.com&utm_medium=referral
A weekly dividend fund holding Nvidia and Palantir
CrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names distributes income every single Thursday, with payouts reported as high as $1,051 a month. Chief Income Strategist Tim Plaehn breaks down the fund's real Thursday distribution history, how the income is generated, and how to buy it in any brokerage account.tc pixel
 |  Investors Alley (Ad)
CLIK Enters Shandong Silver Economy: Care U Signs MOU to Expand Home Nursing into China's Largest Elderly Province via Qingdao Weipu Network
September 1 at 9:00 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/01/3354226/0/en/clik-enters-shandong-silver-economy-care-u-signs-mou-to-expand-home-nursing-into-china-s-largest-elderly-province-via-qingdao-weipu-network.html
Click Holdings Reports Q4 Logistics Revenue Growth Above 42%, Record June Revenue and 135,000+ Service Hours
August 25, 2026  |  quiverquant.comQ
Click Holdings Logistics Segment Surges Over 42% YoY in Q4; Record high HK$4.4 million in June; and 135,000+ Service Hours Drive Operating Leverage and Expansion Momentum
August 25, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/25/3350644/0/en/click-holdings-logistics-segment-surges-over-42-yoy-in-q4-record-high-hk-4-4-million-in-june-and-135-000-service-hours-drive-operating-leverage-and-expansion-momentum.html
See More Click Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Click? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Click and other key companies, straight to your email.

About Click

Click (NASDAQ:CLIK) Therapeutics, Inc. (NASDAQ: CLIK) is a clinical-stage digital therapeutics company developing software-based treatments for neurological, psychiatric and chronic diseases. Its platform delivers prescription digital therapies via mobile and web applications, combining evidence-based cognitive behavioral interventions, digital monitoring tools and patient engagement techniques. Click’s approach is designed to complement or extend traditional pharmacological and behavioral treatments for conditions such as major depressive disorder, insomnia and tobacco use disorder.

Founded in 2014, Click has progressed multiple programs through randomized controlled trials and regulatory review. Several of its lead digital therapeutics have earned Breakthrough Device designation from the U.S. Food and Drug Administration and have pursued CE marking for commercialization in Europe. The company collaborates with pharmaceutical partners, academic institutions and healthcare providers to integrate its digital products into clinical pathways and to collect real-world evidence supporting safety and efficacy.

Headquartered in New York City, Click operates in the United States with strategic alliances in select international markets. Its leadership team draws on deep experience in digital health innovation, neuroscience research and pharmaceutical development. Click continues to invest in research and development, aiming to expand its pipeline into new therapeutic areas and to scale adoption of its digital therapeutics globally.

View Click Profile
Earnings Tools